QQQ   391.62 (+0.30%)
AAPL   194.90 (+0.32%)
MSFT   372.36 (+0.38%)
META   329.50 (+0.89%)
GOOGL   135.34 (-1.16%)
AMZN   146.53 (-0.24%)
TSLA   243.84 (+0.49%)
NVDA   476.89 (+2.35%)
NIO   7.47 (-0.27%)
BABA   72.17 (-0.22%)
AMD   129.91 (+1.20%)
T   16.90 (-1.11%)
F   11.01 (+1.76%)
MU   74.70 (+1.43%)
CGC   0.77 (+6.06%)
GE   120.31 (+0.69%)
DIS   92.86 (+0.55%)
AMC   6.99 (+2.49%)
PFE   28.76 (+0.45%)
PYPL   59.47 (+1.69%)
XOM   99.50 (+1.10%)
QQQ   391.62 (+0.30%)
AAPL   194.90 (+0.32%)
MSFT   372.36 (+0.38%)
META   329.50 (+0.89%)
GOOGL   135.34 (-1.16%)
AMZN   146.53 (-0.24%)
TSLA   243.84 (+0.49%)
NVDA   476.89 (+2.35%)
NIO   7.47 (-0.27%)
BABA   72.17 (-0.22%)
AMD   129.91 (+1.20%)
T   16.90 (-1.11%)
F   11.01 (+1.76%)
MU   74.70 (+1.43%)
CGC   0.77 (+6.06%)
GE   120.31 (+0.69%)
DIS   92.86 (+0.55%)
AMC   6.99 (+2.49%)
PFE   28.76 (+0.45%)
PYPL   59.47 (+1.69%)
XOM   99.50 (+1.10%)
QQQ   391.62 (+0.30%)
AAPL   194.90 (+0.32%)
MSFT   372.36 (+0.38%)
META   329.50 (+0.89%)
GOOGL   135.34 (-1.16%)
AMZN   146.53 (-0.24%)
TSLA   243.84 (+0.49%)
NVDA   476.89 (+2.35%)
NIO   7.47 (-0.27%)
BABA   72.17 (-0.22%)
AMD   129.91 (+1.20%)
T   16.90 (-1.11%)
F   11.01 (+1.76%)
MU   74.70 (+1.43%)
CGC   0.77 (+6.06%)
GE   120.31 (+0.69%)
DIS   92.86 (+0.55%)
AMC   6.99 (+2.49%)
PFE   28.76 (+0.45%)
PYPL   59.47 (+1.69%)
XOM   99.50 (+1.10%)
QQQ   391.62 (+0.30%)
AAPL   194.90 (+0.32%)
MSFT   372.36 (+0.38%)
META   329.50 (+0.89%)
GOOGL   135.34 (-1.16%)
AMZN   146.53 (-0.24%)
TSLA   243.84 (+0.49%)
NVDA   476.89 (+2.35%)
NIO   7.47 (-0.27%)
BABA   72.17 (-0.22%)
AMD   129.91 (+1.20%)
T   16.90 (-1.11%)
F   11.01 (+1.76%)
MU   74.70 (+1.43%)
CGC   0.77 (+6.06%)
GE   120.31 (+0.69%)
DIS   92.86 (+0.55%)
AMC   6.99 (+2.49%)
PFE   28.76 (+0.45%)
PYPL   59.47 (+1.69%)
XOM   99.50 (+1.10%)

Graybug Vision Stock Price, News & Analysis (NASDAQ:GRAY)

$3.38
-0.01 (-0.29%)
(As of 12/7/2023 ET)
Compare
Today's Range
$3.28
$3.40
50-Day Range
$1.78
$4.15
52-Week Range
$5.00
$22.12
Volume
5,102 shs
Average Volume
2,165 shs
Market Capitalization
$5.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

GRAY stock logo

About Graybug Vision Stock (NASDAQ:GRAY)

Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.

GRAY Stock Price History

GRAY Stock News Headlines

Best vision insurance companies of November 2023
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT?
A little-known metal called vanadium is vital to American national security and energy independence. But right now, China and Russia dominate our supply. The U.S. Govt. is so serious about vanadium, it funded and recently completed an "Earth MRI" survey to seek out new sources of this energy metal - in Wyoming.
Graybug Vision Stock (NASDAQ:GRAY), Dividends
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT?
A little-known metal called vanadium is vital to American national security and energy independence. But right now, China and Russia dominate our supply. The U.S. Govt. is so serious about vanadium, it funded and recently completed an "Earth MRI" survey to seek out new sources of this energy metal - in Wyoming.
Graybug Announces Name and Trading Symbol Change
GRAY Graybug Vision, Inc.
Diality Names Pamela Wapnick as Chief Financial Officer
See More Headlines
Receive GRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Graybug Vision and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/11/2021
Today
12/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GRAY
Phone
N/A
Fax
N/A
Employees
27
Year Founded
N/A

Profitability

Net Income
$-35,600,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.67 per share

Miscellaneous

Free Float
20,250,000
Market Cap
$5.32 million
Optionable
Not Optionable
Beta
1.20
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Frederic Guerard Pharm.D. (Age 49)
    Pres, CEO, Sec. & Director
    Comp: $931.02k
  • Mr. Robert S. BreuilMr. Robert S. Breuil (Age 60)
    CFO & Treasurer
    Comp: $577.47k
  • Dr. Gerald D. Cagle Ph.D. (Age 78)
    Sr. Advisor & Head of Bus. Devel.
    Comp: $44.67k
  • Dr. Parisa Zamiri M.D. (Age 57)
    Ph.D., Chief Medical Officer
    Comp: $662.11k
  • Dr. Peter A. Campochiaro M.D.
    Co-Founder
  • Dr. Peter J. McDonnell M.D. (Age 63)
    Co-Founder
  • Ms. Bettina Maunz
    Chief People Officer & Head of Communications
  • Mr. Ming Yang
    Sr. VP of R&D
  • Dr. Ward M. Peterson Ph.D.
    Sr. VP of Preclinical Devel.
  • Mr. Ali Kakavand Ph.D.
    VP & Head of Program Management














GRAY Stock Analysis - Frequently Asked Questions

How have GRAY shares performed in 2023?

Graybug Vision's stock was trading at $7.00 on January 1st, 2023. Since then, GRAY stock has decreased by 51.6% and is now trading at $3.3850.
View the best growth stocks for 2023 here
.

How were Graybug Vision's earnings last quarter?

Graybug Vision, Inc. (NASDAQ:GRAY) issued its quarterly earnings results on Thursday, November, 11th. The company reported ($5.32) earnings per share for the quarter, missing analysts' consensus estimates of ($5.18) by $0.14.

When did Graybug Vision's stock split?

Shares of Graybug Vision reverse split before market open on Monday, March 20th 2023. The 1-14 reverse split was announced on Monday, March 20th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, March 20th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Graybug Vision IPO?

(GRAY) raised $75 million in an initial public offering on Friday, September 25th 2020. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. SVB Leerink and Piper Sandler served as the underwriters for the IPO and Needham & Co. and Wedbush PacGrow were co-managers.

Who are Graybug Vision's major shareholders?

Graybug Vision's stock is owned by many different retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends
.

How do I buy shares of Graybug Vision?

Shares of GRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:GRAY) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -